Painless Microneedle System Helps Monitor Drug Levels
By HospiMedica International staff writers Posted on 24 Aug 2016 |
Image: The microneedle-optofluidic biosensor drug monitoring system (Photo courtesy of UBC).
A novel microneedle monitoring system measures drug levels in the skin, without the need for drawing blood for analysis.
Developed by researchers at the University of British Columbia (UBC, Vancouver, Canada) and the Paul Scherrer Institut (PSI; Villigen, Switzerland), the new system consists of a small patch pressed against a patient’s arm for therapeutic drug monitoring (TDM) during medical treatment. The patch contains an integrated, hollow microneedle-optofluidic biosensor with needle-like projections less than half a millimeter long, which extract extremely small volumes--less than one nanoliter--of interstitial fluid (ISF).
The inner lumen of the microneedle is functionalized to be used as a micro-reactor during sample collection, trapping and binding target drug candidates during extraction, without the requirement of a sample transfer. An optofluidic device is integrated within the microneedle to rapidly quantify drug analytes with high sensitivity, using a straightforward absorbance scheme. In a clinical study, the antibiotic vancomycin was detected using ISF volumes that ranged between 50–100 μL. The study was published on July 6, 2106, in Scientific Reports.
“The microneedles resemble hollow cones and are less than half a millimeter in length; they are designed to puncture only the outer layer of skin, which acts as a protective barrier, but not the epidermis or dermis, which comprise nerves, blood vessels, and active immune cells,” said senior author Victor Cadarso, PhD, of PSI. “The combination of knowhow from UBC and PSI, bringing together microneedles, microfluidics, optics, and biotechnology, allowed us to create a device capable of both collecting the fluid and performing the analysis.”
ISF surrounds all tissue cells. It is advantageous in biosensing applications, since it does not contain any particulates such as red blood cells or platelets, and contains at least 5–10 times less protein than blood serum. But only extremely low volumes are found in human skin, making the process of ISF extraction rather difficult.
Related Links:
University of British Columbia
Paul Scherrer Institut
Developed by researchers at the University of British Columbia (UBC, Vancouver, Canada) and the Paul Scherrer Institut (PSI; Villigen, Switzerland), the new system consists of a small patch pressed against a patient’s arm for therapeutic drug monitoring (TDM) during medical treatment. The patch contains an integrated, hollow microneedle-optofluidic biosensor with needle-like projections less than half a millimeter long, which extract extremely small volumes--less than one nanoliter--of interstitial fluid (ISF).
The inner lumen of the microneedle is functionalized to be used as a micro-reactor during sample collection, trapping and binding target drug candidates during extraction, without the requirement of a sample transfer. An optofluidic device is integrated within the microneedle to rapidly quantify drug analytes with high sensitivity, using a straightforward absorbance scheme. In a clinical study, the antibiotic vancomycin was detected using ISF volumes that ranged between 50–100 μL. The study was published on July 6, 2106, in Scientific Reports.
“The microneedles resemble hollow cones and are less than half a millimeter in length; they are designed to puncture only the outer layer of skin, which acts as a protective barrier, but not the epidermis or dermis, which comprise nerves, blood vessels, and active immune cells,” said senior author Victor Cadarso, PhD, of PSI. “The combination of knowhow from UBC and PSI, bringing together microneedles, microfluidics, optics, and biotechnology, allowed us to create a device capable of both collecting the fluid and performing the analysis.”
ISF surrounds all tissue cells. It is advantageous in biosensing applications, since it does not contain any particulates such as red blood cells or platelets, and contains at least 5–10 times less protein than blood serum. But only extremely low volumes are found in human skin, making the process of ISF extraction rather difficult.
Related Links:
University of British Columbia
Paul Scherrer Institut
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure